Withdrawal symptoms from transdermal fentanyl (TDF) after an allogeneic peripheral blood stem cell transplant (PBSCT)

Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Yutaka TsutsumiNobuo Masauzi

Abstract

A 47-year-old woman who underwent allogenic peripheral blood stem cell transplant developed withdrawal symptoms soon after Fentanyl 25 mcg/h patch was stopped, which has not been reported at this dose. Possible causes, such as the inhibition of CYP3A4 induced by cyclosporine causing elevations of serum fentanyl, are discussed.

References

Jan 1, 1994·Journal of Pain and Symptom Management·M ZenzM Strumpf
Jan 1, 1995·Journal of Pain and Symptom Management·C M Higgs, J Vella-Brincat
Sep 15, 1999·Anesthesiology·K T OlkkolaP J Neuvonen
Mar 21, 2002·The Lancet Oncology·G K Gourlay

❮ Previous
Next ❯

Citations

Sep 1, 2006·Photomedicine and Laser Surgery
Aug 12, 2009·Journal of Pain & Palliative Care Pharmacotherapy·Simon HaroutiunianElyad Davidson

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Revue des maladies respiratoires
C CordonnierS Maury
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
In-Sung ChoiSam-Gyu Lee
Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)
T de la Calle CabreraL Madero López
© 2022 Meta ULC. All rights reserved